Search company, investor...

Predict your next investment

C.R. Bard company logo
Corporation
HEALTHCARE | Medical Devices & Equipment / Device Design & Manufacturing
crbard.com

Investments

3

Partners & Customers

1

About C.R. Bard

C. R. Bard (NYSE: BCR), is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology, and surgical specialties. Bard markets its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. It was founded in 1907 and is based in New Providence, New Jersey. In December 2017, C.R. Bard was acquired by BD.

Headquarters Location

730 Central Avenue

New Providence, New Jersey, 07974-1199,

United States

908-277-8000

Want to inform investors similar to C.R. Bard about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Expert Collections containing C.R. Bard

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find C.R. Bard in 2 Expert Collections, including Cancer.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

M

Medical Devices

3,383 items

Companies that received PMA from the FDA since 2014. Companies tagged as #FDAPMA

Latest C.R. Bard News

Dynamics of Guidewires Market: Enhancing Medical Navigation | Medtronic, Terumo, Cook Group, Teleflex

May 19, 2023

| Medtronic, Terumo, Cook Group, Teleflex News Provided By Share This Article Guidewires Market1 PORTLAND, OR, UNITED STATES, May 20, 2023 / EINPresswire.com / -- Guidewires Market - Global Outlook and Forecast 2023-2030 is latest research study released by Allied Market Research evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support (2023-2030). The market Study is segmented by key a region that is accelerating the marketization. The report provides information on market research and development, growth drivers, and the changing investment structure of the Global Guidewires Market. Some of the key players profiled in the study are Boston Scientific Corporation, Medtronic, Terumo Corporation, Cook Group, Abbott Laboratories, Cardinal Health, Stryker Corporation, Olympus Corporation, Johnson & Johnson, B. Braun Melsungen AG, Teleflex Incorporated, Angiodynamics, C.R. Bard. Click To get FREE SAMPLE PDF (Including Full TOC, Table & Figures): https://www.alliedmarketresearch.com/request-toc-and-sample/7993 Guidewires are medical devices used in various minimally invasive procedures to assist in the placement and navigation of catheters, stents, or other medical instruments within the body. They are thin, flexible wires with a tapered or rounded tip that allows for easier insertion and maneuverability through blood vessels, ducts, or other anatomical structures. Guidewires are commonly made of stainless steel or nitinol, which provides flexibility, strength, and radiopacity for better visualization during procedures. The primary function of a guidewire is to create a pathway and provide guidance for the placement of other medical devices. The guidewire is usually inserted through a small puncture site or an existing catheter, and it is then advanced under fluoroscopic or imaging guidance to the desired location within the body. Once in place, the guidewire provides stability and support for subsequent instruments or devices to be inserted over it, such as angioplasty balloons, stents, or drainage catheters. Guidewires come in various lengths, diameters, and designs to accommodate different procedures and anatomical structures. Guidewires Market: Demand Analysis & Opportunity Outlook 2030 Guidewires research study defines market size of various segments & countries by historical years and forecast the values for next 7 years. The report is assembled to comprise qualitative and quantitative elements of Guidewires industry including: market share, market size (value and volume 2017-2021, and forecast to 2030) that admires each country concerned in the competitive marketplace. Further, the study also caters and provides in-depth statistics about the crucial elements of Guidewires which includes drivers & restraining factors that helps estimate future growth outlook of the market. Marketing Communication and Sales Channel Understanding “marketing effectiveness” on a continual basis, help determine the potential of advertising and marketing communications and allow to use of best practices to utilize untapped audience. In order to make marketers make effective strategies and identify why the target market is not giving attention, we ensure the Study is Segmented with appropriate marketing & sales channels to identify potential market size by value & Volume* (if Applicable). Have Any Query? Ask Our Expert @: https://www.alliedmarketresearch.com/purchase-enquiry/7993 The segments and sub-section of Guidewires market is shown below: By Material: Nitinol Guidewires, Stainless Steel Guidewires, Hybrid Guidewires By Product: Surgical Guidewires, Diagnostic Guidewires By Application: Cardiology Applications, Vascular Applications, Neurology Applications, Urology Applications, Gastroenterology Applications, Oncology Applications, Otolaryngology Applications By End Users: Hospitals, Diagnostic Centers, and Surgical Centers, Ambulatory Care Centers (ACC), Research Laboratories & Academic Institutes Some of the key players involved in the Market are: Boston Scientific Corporation, Medtronic, Terumo Corporation, Cook Group, Abbott Laboratories, Cardinal Health, Stryker Corporation, Olympus Corporation, Johnson & Johnson, B. Braun Melsungen AG, Teleflex Incorporated, Angiodynamics, C.R. Bard. Important years considered in the Guidewires study: Historical year – 2017-2021; Base year – 2021; Forecast period** – 2022 to 2030 [** unless otherwise stated] If opting for the Global version of Guidewires Market; then below country analysis would be included: – North America (USA, Canada and Mexico) – Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland and Rest of Europe) – Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia and Rest of APAC) – South America (Brazil, Argentina, Chile, Colombia, Rest of countries etc.) – Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA) Key Questions Answered with this Study: 1) What makes Guidewires Market feasible for long term investment? 2) How influencing factors driving the demand of Guidewires in next few years? 3) Territory that may see steep rise in CAGR & Y-O-Y growth? 4) What geographic region would have better demand for product/services? 5) What opportunity emerging territory would offer to established and new entrants in Guidewires market? 6) What strategies of big players help them acquire share in mature market? 7) Know value chain areas where players can create value? 8) What is the impact analysis of various factors in the Global Guidewires market growth? 9) Risk side analysis connected with service providers? Introduction about Guidewires Market Guidewires Market by Application/End Users Guidewires Sales (Volume) and Market Share Comparison by Applications Global Guidewires Sales and Growth Rate (2020-2030) Guidewires Competition by Players/Suppliers, Region, Type, and Application Guidewires (Volume, Value, and Sales Price) table defined for each geographic region defined. Guidewires Players/Suppliers Profiles and Sales Data Key Raw Materials Analysis & Price Trends Supply Chain, Sourcing Strategy and Downstream Buyers, Industrial Chain Analysis ……..and view more in complete table of Contents Procure Complete Report (220+ Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/checkout-final/f4c4947d645b13a0a95c77bdbf7a37ef Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia. Read More Articles: PCOS Treatment Market Update 2023–2030: https://www.einpresswire.com/article/627306109/polycystic-ovarian-syndrome-pcos-treatment-market-expected-to-reach-us-4-1-billion-by-2026-cagr-4-7-pdf-version U.S. Topical Pain Relief Market Update 2023–2030: https://www.einpresswire.com/article/627568484/topical-pain-relief-market-expected-to-reach-us-3-2-billion-by-2027-cagr-3-7-pdf-version David Correa

C.R. Bard Investments

3 Investments

C.R. Bard has made 3 investments. Their latest investment was in Unisurge as part of their Series B on June 6, 1993.

CBI Logo

C.R. Bard Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/30/1993

Series B

Unisurge

$8.48M

No

1

4/1/1992

Series A

Subscribe to see more

$99M

Subscribe to see more

10

6/1/1991

Seed

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/30/1993

4/1/1992

6/1/1991

Round

Series B

Series A

Seed

Company

Unisurge

Subscribe to see more

Subscribe to see more

Amount

$8.48M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

10

10

C.R. Bard Acquisitions

17 Acquisitions

C.R. Bard acquired 17 companies. Their latest acquisition was LifeBond on January 15, 2020.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/15/2020

Series D

$99M

$67.5M

Acquired

1

1/22/2016

$99M

Acq - P2P

1

7/1/2015

Debt

$99M

$24.53M

Acquired

1

9/4/2013

Subscribe to see more

$99M

Subscribe to see more

10

8/20/2013

Other

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

1/15/2020

1/22/2016

7/1/2015

9/4/2013

8/20/2013

Investment Stage

Series D

Debt

Other

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

$67.5M

$24.53M

$99M

Note

Acquired

Acq - P2P

Acquired

Subscribe to see more

Subscribe to see more

Sources

1

1

1

10

10

C.R. Bard Partners & Customers

1 Partners and customers

C.R. Bard has 1 strategic partners and customers. C.R. Bard recently partnered with Boston Scientific on October 10, 2014.

C.R. Bard Team

11 Team Members

C.R. Bard has 11 team members, including current President, Benson F Smith.

Name

Work History

Title

Status

Benson F Smith

President

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Benson F Smith

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

President

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.